Join EVA Pharma, a leading pharmaceutical company dedicated to empowering the fight for Health and well-being as a fundamental human right. Recognized and certified as a best place to work, we are committed to fostering a supportive and innovative environment for our team members.
EVA Pharma is seeking an experienced Business Development Manager – Emerging Markets to drive strategic partnerships and licensing opportunities with Global pharmaceutical companies. The ideal candidate will have a strong background in pharma business development—especially in biosimilars and biologics—proven negotiation skills, and the ability to build impactful relationships in different markets. Advanced scientific and business qualifications are required.
Key Responsibilities:
• Identify and evaluate in-licensing and out-licensing opportunities with Chinese pharmaceutical and biotech companies, with a focus on biosimilars , New Chemical Entities and New Biological Entities.
• Lead negotiations and structure strategic deals that align with EVA Pharma’s global growth objectives and regulatory requirements in China.
• Build and nurture strong relationships with key Chinese stakeholders, including regulators, manufacturers, and commercial partners.
• Monitor market trends, policy developments, and competitive dynamics in China to guide portfolio strategy and business development decisions in the important markets for Eva Pharma
Requirements
EVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products.
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies.
Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand.
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 60 countries worldwide.
